logo

Cytodyn Inc. (CYDY.OB)



Trade CYDY.OB now with
  Date
  Headline
4/5/2021 6:25:36 AM CytoDyn Completes An Additional Potentially Non-dilutive Convertible Debt Offering
4/1/2021 6:04:37 AM CytoDyn Files New Protocol With FDA For 4 Doses Of Leronlimab For Critically Ill COVID-19 Patients
3/30/2021 6:06:36 AM CytoDyn Announces Further Results From CD12 Trial Of Severe-to-critically Ill Patients With COVID-19
3/29/2021 6:08:45 AM CytoDyn: The Philippines FDA Approves Use Of Leronlimab To Treat COVID-19 Patient
12/31/2020 1:05:48 AM CytoDyn Publishes Research Manuscript On Critically Ill COVID-19 Patients In Journal Of Translational Autoimmunity
12/30/2020 1:51:58 AM CytoDyn To Hold Webcast On January 6 To Provide Timelines For Clinical, Regulatory Developments
12/22/2020 6:28:00 AM CytoDyn: FDA Resumes EIND Approval For Severe-to-Critical COVID-19 Patients Use Of Vyrologix
12/2/2020 6:11:54 AM CytoDyn: First Patient First Visit Metric Met For Phase 2 Trial For Nonalcoholic Steatohepatitis
11/17/2020 9:10:41 AM CytoDyn Files Protocol With FDA For Phase 2 Trial For COVID-19 Patients With Long-Hauler Symptoms
10/27/2020 12:49:37 AM CytoDyn Says U.K. MHRA Clears CytoDyn To File BLA For Leronlimab As One Injection Per Week For Combination HIV Therapy
8/19/2020 2:56:46 AM CytoDyn Announces Upcoming Retirement Of David Welch From Its Board
8/19/2020 2:55:37 AM CytoDyn Requests Fast Track Approval For COVID-19 Patients From U.K.'s Regulatory Agency MHRA
8/17/2020 6:03:05 AM CytoDyn Submits Top-line Report From Phase 2 COVID-19 Trial To FDA